[1] |
Charras A, Smith E, Hedrich CM. Systemic lupus erythematosus in children and young people[J]. Curr Rheumatol Rep, 2021, 23(3): 20.
doi: 10.1007/s11926-021-00985-0
pmid: 33569643
|
[2] |
Osaku FM, Fraga MM, Aires PP, et al. SLICC classification criteria for juvenile systemic lupus erythematosus: a cross sectional study[J]. Acta Reumatol Port, 2018, 43(4): 279-283.
pmid: 30641536
|
[3] |
Frittoli RB, Vivaldo JF, Costallat LTL, et al. Gastrointestinal involvement in systemic lupus erythematosus: asystematic review[J]. J Transl Autoimmun, 2021, 4: 100106.
|
[4] |
Leone P, Prete M, Malerba E, et al. Lupus vasculitis: an overview[J]. Biomedicines, 2021, 9(11): 1626.
|
[5] |
Koga T, Ichinose K, Kawakami A, et al. Current insights and future prospects for targeting IL-17 to treat patients with systemic lupus erythematosus[J]. Front Immunol, 2021, 11: 624971.
|
[6] |
Hatemi I, Hatemi G, Çelik AF. Systemic vasculitis and the gut[J]. Curr Opin Rheumatol, 2017, 29(1): 33-38.
pmid: 27684357
|
[7] |
Calle-Botero E, Abril A. Lupus vasculitis[J]. Curr Rheumatol Rep, 2020, 22(10): 71.
doi: 10.1007/s11926-020-00937-0
pmid: 32845454
|
[8] |
Alharbi S. Gastrointestinal manifestations in patients with systemic lupus erythematosus[J]. Open Access Rheumatol, 2022, 14: 243-253.
|
[9] |
Halabi H, AlDabbagh A, Alamoudi A. Gastrointestinal manifestations of rheumatic diseases[M]//Almoallim H, Cheikh M, editors. Skills in rheumatology. Singapore: Springer, 2021: Chapter 23.
|
[10] |
Liu F, Ren T, Li X, et al. Distinct microbiomes of gut and saliva in patients with systemic lupus erythematous and clinical associations[J]. Front Immunol, 2021, 12: 626217.
|
[11] |
Girardelli M, Valencic E, Moressa V, et al. Genetic and immunologic findings in children with recurrent aphthous stomatitis with systemic inflammation[J]. Pediatr Rheumatol Online J, 2021, 19(1): 70.
doi: 10.1186/s12969-021-00552-y
pmid: 33971891
|
[12] |
Chua S, Dodd H, Saeed IT, et al. Dysphagia in a patient with lupus and review of the literature[J]. Lupus, 2002, 11(5): 322-324.
pmid: 12090569
|
[13] |
Carlé C, Mas E, Barreau F. Intestinal involvement in lupus: From pathophysiology to therapeutic perspectives[J]. Lupus, 2023, 32(4): 461-470.
|
[14] |
王康健, 陈宏浦, 吕国荣, 等. 胃充盈超声造影对系统性红斑狼疮胃受累的诊断价值[J]. 中国超声医学杂志, 2016, 32(5): 437-439.
|
[15] |
Alsolaimani R. Mesenteric vasculitis and urinary system involvement presenting as the initial manifestations of systemic lupus erythematosus treated successfully with glucocorticoids and rituximab: a case report[J]. Cureus, 2022, 14(11): e31474.
|
[16] |
Xie JJ, Ling GC, Jiang YB, et al. Lupus with initial mesenteric vasculitis[J]. Rheumatol Immunol Res, 2023, 4(2): 102-103.
|
[17] |
Medina F, Ayala A, Jara LJ, et al. Acute abdomen in systemic lupus erythematosus: the importance of early laparotomy[J]. Am J Med, 1997, 103(2): 100-105.
doi: 10.1016/s0002-9343(97)80020-4
pmid: 9274892
|
[18] |
Ayari M, Nakhli A, Teyeb Z, et al. Intestinal pseudo-obstruction: unusual presentation of systemic lupus erythematous[J]. Clin Case Rep, 2021, 9(3): 1759-1762.
|
[19] |
Ohri AJ, Shah CG, Udani AH. Intestinal pseudo-obstruction - an under-recognized presentation of systemic lupus erythematosus[J]. Indian J Nephrol, 2022, 32(5): 476-479.
doi: 10.4103/ijn.IJN_494_20
pmid: 36568587
|
[20] |
Zheng J, Ni R, Liu H. Intestinal pseudo-obstruction in systemic lupus erythematosus: an analysis of nationwide inpatient sample[J]. Clin Rheumatol, 2022, 41(11): 3331-3335.
doi: 10.1007/s10067-022-06283-z
pmid: 35819642
|
[21] |
Eguchi M, Iwanaga N, Sakai K, et al. Protein-losing gastroenteropathy in a patient with concomitant systemic lupus erythematosus and Sjögren's syndrome[J]. Immunol Med, 2018, 41(1): 34-38.
doi: 10.1080/09114300.2018.1451614
pmid: 30938260
|
[22] |
Li Z, Xu D, Wang Z, et al. Gastrointestinal system involvement in systemic lupus erythematosus[J]. Lupus. 2017, 26(11): 1127-1138.
doi: 10.1177/0961203317707825
pmid: 28523968
|
[23] |
Lin Q, Zhang M, Tang H, et al. Acute pancreatitis and macrophage activation syndrome in pediatric systemic lupus erythematosus: case-based review[J]. Rheumatol Int, 2020, 40(5): 811-819.
doi: 10.1007/s00296-019-04388-4
pmid: 31377830
|
[24] |
Gormezano NW, Otsuzi CI, Barros DL, et al. Macrophage activation syndrome: a severe and frequent manifestation of acute pancreatitis in 362 childhood-onset compared to 1830 adult-onset systemic lupus erythematosus patients[J]. Semin Arthritis Rheum, 2016, 45(6): 706-710.
|
[25] |
El Qadiry R, Bourrahouat A, Aitsab I, et al. Systemic lupus erythematosus-related pancreatitis in children: severe and lethal form[J]. Case Rep Pediatr, 2018, 2018: 4612754.
|
[26] |
Dima A, Balaban DV, Jurcut C, et al. Systemic lupus erythematosus-related acute pancreatitis[J]. Lupus, 2021, 30(1): 5-14.
doi: 10.1177/0961203320978515
pmid: 33307986
|
[27] |
Marques VL, Gormezano NW, Bonfá E, et al. Pancreatitis subtypes survey in 852 childhood-onset systemic lupus erythematosus patients[J]. J Pediatr Gastroenterol Nutr, 2016, 62(2): 328-334.
|
[28] |
Abughazaleh S, Alsakarneh S, Hattar M, et al. Systemic lupus erythematosus in disguise: acute pancreatitis as initial presentation[J]. J Investig Med High Impact Case Rep, 2023, 11: 23247096231185480.
|
[29] |
González-Regueiro JA, Cruz-Contreras M, Merayo-Chalico J, et al. Hepatic manifestations in systemic lupus erythematosus[J]. Lupus, 2020, 29(8): 813-824.
doi: 10.1177/0961203320923398
pmid: 32390496
|
[30] |
Adiga A, Nugent K. Lupus hepatitis and autoimmune hepatitis (lupoid hepatitis)[J]. Am J Med Sci, 2017, 353(4): 329-335.
doi: S0002-9629(16)30600-0
pmid: 28317620
|
[31] |
Tani C, Elefante E, Arnaud L, et al. Rare clinical manifestations in systemic lupus erythematosus: a review on frequency and clinical presentation[J]. Clin Exp Rheumatol, 2022, 134(5): 93-102.
|
[32] |
Mendonça JA, Marques-Neto JF, Prando P, et al. Acute acalculous cholecystitis in juvenile systemic lupus erythematosus[J]. Lupus, 2009, 18(6): 561-563.
doi: 10.1177/0961203308098587
pmid: 19395459
|
[33] |
Xu H, Meng X, Wang L, et al. Dietary patterns and life-styles of patients with gastrointestinal involvement of systemic lupus erythematosus: Questionnaire survey from a tertiary center of China[J]. Lupus, 2023, 32(4): 477-488.
|
[34] |
Luo S, Long H, Lu Q. Recent advances in understanding pathogenesis and therapeutic strategies of systemic lupus erythematosus[J]. Int Immunopharmacol, 2020, 89: 107028.
|
[35] |
Trindade VC, Carneiro-Sampaio M, Bonfa E, et al. An update on the management of childhood-onset systemic lupus erythematosus[J]. Paediatr Drugs, 2021, 23(4): 331-347.
doi: 10.1007/s40272-021-00457-z
pmid: 34244988
|
[36] |
Kenar G, Atay K, Yüksek GE, et al. Gastrointestinal vasculitis due to systemic lupus erythematosus treated with rituximab: a case report[J]. Lupus, 2020, 29(6): 640-643.
doi: 10.1177/0961203320910803
pmid: 32188302
|
[37] |
朱万红, 王秀丽, 赵成广, 等. 贝利尤单抗治疗以呕吐尿频为首发症状的儿童系统性红斑狼疮一例[J]. 国际儿科学杂志, 2021, 48(3): 214-216.
|
[38] |
Mauro A, Giani T, Di Mari C, et al. Gastrointestinal involvement in children with systemic lupus erythematosus[J]. Children (Basel), 2023, 10(2): 309.
|
[39] |
Trapani S, Rubino C, Simonini G, et al. Gastrointestinal and hepatic involvement in paediatric systemic lupus erythematosus[J]. Clin Exp Rheumatol, 2021, 39(4): 899-906.
doi: 10.55563/clinexprheumatol/oebrcq
pmid: 33666164
|